Providing Standardized Consented PROMs (Patient Reported Outcome Measures) for Improving Pain Treatment (PROMPT)

November 1, 2022 updated by: Prof. Dr. Winfried Meissner

PROMPT Providing Standardized Consented PROMs (Patient Reported Outcome Measures) for Improving Pain Treatment A Multicenter, Non-interventional, Prospective Observational Study

PROMPT aims at improving management of acute and chronic pain by identifying a core set of PROMs (patient reported outcome measures) that are predictive indicators of treatment success in clinical practice and controlled trials. These will not only address pain intensities as well as the functional consequences of pain for individuals but also identify patients at risk of experiencing chronification of acute post-operative pain. Results will help health care professionals to individualize pain management, and thus improve the quality of life of pain patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

In order to reach this objective, a non-interventional prospective data collection aiming at reaching a consensus on a core set of PROMs which reliably predict and/or measure success in acute and chronic pain treatments in real life conditions and identifying predictors for chronification of postoperative pain will be conducted (PROMPT NIT-1). Aim of the data collection is to evaluate the abilities of certain PROMs in assessing acute post-surgical pain outcomes in daily routine care of patients after four different surgical procedures: (total knee replacement, breast surgery, sternotomy and surgery related to endometriosis), and to validate selected risk factors for chronification prospectively.

Study Type

Observational

Enrollment (Actual)

3322

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Thuringia
      • Jena, Thuringia, Germany, 07747
        • Jena University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients undergoing one of the following types of surgery: TKA, breast, sternotomy and endometriosis related surgery. Only female patients will be included in the Breast Surgery and Endometriosis group. For the other surgeries, there will not be a special preference in the distribution by sex or age for the recruitment.

Description

Inclusion Criteria:

  • Patient is of consenting age (>18 years old)
  • Elective surgery
  • Planned stay in hospital for the surgery
  • First contact with the patient before surgery
  • Patient agrees to participate

Exclusion Criteria:

  • Patient is unable to give consent
  • Cognitive impairment
  • Questionnaire is not available in a language the patient is fluent in
  • Patient not willing to answer the follow-up questionnaire

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Total knee arthroplasty
Patients undergoing total knee arthroplasty
No intervention. It's a prospective data collection.
Sternotomy
Patients undergoing sternotomy
No intervention. It's a prospective data collection.
Breast
Patients undergoing breast surgery
No intervention. It's a prospective data collection.
Endometriosis
Patients undergoing endometriosis-related surgery
No intervention. It's a prospective data collection.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
WP 2 - Acute pain: Sensitivity to change
Time Frame: 2019 - 2022
For WP2, the primary endpoint will be pain intensity at day 3 (NRS Scale from 0 to 10, 0 being no pain, 10 being worst pain imaginable). This primary endpoint (PROMs) will be used to assess sensitivity to change from POD3 to POD1.
2019 - 2022
WP 3 - Chronification of pain: Incidence of chronic post-surgical pain (CPSP)
Time Frame: 2019 - 2022
For WP3, the primary end point will be the incidence of moderate to severe CPSP (Numeric rating scale ≥ 3/10) at 6 months using the average pain on the Brief Pain Inventory Questionnaire.
2019 - 2022

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Objective physical activity and sleep, measured with Actigraph devices
Time Frame: 01/2020 to 12/2021
Correlation of physical activity data (average no. of steps of days 5 to 7) with PRO "physical function" on day 7;
01/2020 to 12/2021
Association between other POD7 PROMs and activity/sleep
Time Frame: 01/2020 to 12/2021
Association between other POD7 PROMs and activity/sleep
01/2020 to 12/2021
Association between peri-operative processes and activity/sleep
Time Frame: 01/2020 to 12/2021
Association between peri-operative processes and activity/sleep
01/2020 to 12/2021
Is decreased activity a predictor for chronic postsurgical pain?
Time Frame: 01/2020 to 12/2021
Is decreased activity a predictor for chronic postsurgical pain on POM6?
01/2020 to 12/2021
Do activity trajectories since surgery parallel trajectories of other outcomes?
Time Frame: 01/2020 to 12/2021
Do activity trajectories since surgery parallel trajectories of other outcomes?
01/2020 to 12/2021
Correlation of activity difference between POD5-7 and preop with POD7 oucomes
Time Frame: 01/2020 to 12/2021
Correlation of activity difference between POD5-7 and preop with POD7 oucomes
01/2020 to 12/2021
Association between ambient light intensity and outcomes on POD7
Time Frame: 01/2020 to 12/2021
Association between ambient light intensity and outcomes on POD7
01/2020 to 12/2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 24, 2019

Primary Completion (Actual)

June 30, 2022

Study Completion (Actual)

June 30, 2022

Study Registration Dates

First Submitted

February 7, 2019

First Submitted That Met QC Criteria

February 7, 2019

First Posted (Actual)

February 8, 2019

Study Record Updates

Last Update Posted (Actual)

November 2, 2022

Last Update Submitted That Met QC Criteria

November 1, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on Prospective data collection

Subscribe